Royce captopril ANDA cleared for FDA approval review by Miami federal court.
Executive Summary
ROYCE CAPTOPRIL ANDA CLEARED FOR APPROVAL BY MIAMI FEDERAL COURT, Royce Labs announced Aug. 25. In responding to Royce's emergency motion filed Aug. 11, the court ordered that Bristol's patent infringement complaint be dismissed and the stay of approval on Royce's generic version of Capoten be lifted.